about
Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanismTherapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.Immunity as a predictor of anti-malarial treatment failure: a systematic reviewIntravenous artesunate for the treatment of severe malaria.Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover studySubchronic toxicological study of two artemisinin derivatives in dogsOptimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malariaPharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteersPrevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New GuineaDose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.Artemisinin effectiveness in erythrocytes is reduced by heme and heme-containing proteins.Assessment of safety of the major antimalarial drugs.Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.Towards optimal design of anti-malarial pharmacokinetic studies.General Pharmacology of Artesunate, a Commonly used Antimalarial Drug:Effects on Central Nervous, Cardiovascular, and Respiratory System.Tropical American plants in the treatment of infectious diseases.In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100).A randomized, comparative study of two regimens of beta-artemether for the treatment of uncomplicated, Plasmodium falciparum malaria, in northern Ghana.Artesunate inhibits proliferation of naïve CD4(+) T cells but enhances function of effector T cells.First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisoneEffect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria.In vitro evaluation of the genotoxic and cytotoxic effects of artesunate, an antimalarial drug, in human lymphocytes.The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria.Artesunate protects pancreatic beta cells against cytokine-induced damage via SIRT1 inhibiting NF-κB activation.Skin prick test results to artesunate in children sensitized to Artemisia vulgaris L.Simultaneous Determination of Artesunate and Dihydroartemisinin Concentrations in Human Plasma by High Performance Liquid Chromatography-Mass Spectrometry with Electro-Spray Ionization
P2860
Q24675578-A0E74F03-8131-4D91-AFE2-18BF63FEB540Q31118886-A469C8BC-64FE-4FF8-A5EB-D9A2B9428061Q33582154-4BA91EBD-BC5F-408A-B62B-250DE3321F28Q34120984-A9B1FCCC-8FD0-4C1E-9303-45695888B5B9Q35056250-81CD62A0-0DF8-4217-B165-0EF5CB1AA486Q35150376-B7F8ECF3-07DA-4649-9267-F0AB2896CA7EQ35163623-290C22EA-985B-4063-A810-956CF42C4FC9Q35191531-A971AFA0-DC9A-4254-9106-6D47F0356087Q35669950-56CD2F8A-E250-4255-B97A-20C299BFDFB3Q35803874-1D838EE0-12DA-41CD-B891-6CAA7A47D1BBQ35804118-01231BE1-0DAF-49F4-AF6C-0213C1947F1EQ35827084-91AC9C8C-8A3C-442E-80C3-8683EA88C9A0Q35943679-2F7EC623-E133-420A-8CCA-300D724CBFC1Q36945007-7200671A-B714-41DE-B996-07788D9A9E1EQ36959519-0DF46CA6-D081-43FE-9AE5-0709050DDE6CQ37320525-A6FDDBA3-41FC-40D7-88D2-5D481CCE0068Q37326574-BB9569F1-4EC8-477F-ACA5-A39902957290Q37995762-6BC2CA30-A9B9-478D-9695-B8A6521B2143Q39467093-5B8AB1C3-B256-4510-8887-BF8D9B00F912Q40529712-33B9FA87-17C7-43FD-B4C2-CF8B149FE343Q42182185-16A5DDBE-29B2-4EEE-8038-C4499957DD26Q42445249-BB5E2902-EC00-4E3A-BD06-ED0B5AD5A8F6Q43452416-620A2389-BA8F-4EBE-85A5-F1A31215F297Q44594613-DCBB4E49-A248-46D2-B022-4A6C3E951CA9Q45981965-27408C45-A0F3-4E42-A35A-172F499DC29BQ46814340-3F51D46D-3A57-4BA2-A8F7-3AF2038C8B0DQ47917268-D9A688C2-E9A9-4B33-BF44-FBF7C72606DFQ50853269-A961705D-BE87-442A-8257-DDCB3BE36B74Q58145235-AB04AE4C-8D20-42B6-920B-51B438FFD24C
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Artemisinin drugs: novel antimalarial agents.
@ast
Artemisinin drugs: novel antimalarial agents.
@en
Artemisinin drugs: novel antimalarial agents.
@nl
type
label
Artemisinin drugs: novel antimalarial agents.
@ast
Artemisinin drugs: novel antimalarial agents.
@en
Artemisinin drugs: novel antimalarial agents.
@nl
prefLabel
Artemisinin drugs: novel antimalarial agents.
@ast
Artemisinin drugs: novel antimalarial agents.
@en
Artemisinin drugs: novel antimalarial agents.
@nl
P2860
P1476
Artemisinin drugs: novel antimalarial agents.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.8.1815
P407
P577
2000-08-01T00:00:00Z